Sippican Capital Advisors Danaher Corp Transaction History

Sippican Capital Advisors

$130 Million
Q3 2024

A detailed history of Sippican Capital Advisors transactions in Danaher Corp stock. As of the latest transaction made, Sippican Capital Advisors holds 941 shares of DHR stock, worth $228,493. This represents 0.2% of its overall portfolio holdings.

Number of Shares

941

Previous 941 -0.0%

Holding current value

$228,493

Previous $235,000 11.06%

% of portfolio

0.2%

Previous 0.2%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$233.08 - $265.59 $13,285 - $15,138	-57 Reduced 5.71%	941 $233,000
Q3 2021 Oct 20, 2021	SELL	$272.21 - $332.43 $5,444 - $6,648	-20 Reduced 1.96%	998 $304,000
Q2 2021 Jul 22, 2021	SELL	$225.08 - $271.69 $900 - $1,086	-4 Reduced 0.39%	1,018 $273,000
Q1 2021 Apr 15, 2021	SELL	$212.38 - $245.9 $2,548 - $2,950	-12 Reduced 1.16%	1,022 $230,000
Q4 2020 Jan 21, 2021	SELL	$212.5 - $245.46 $21,462 - $24,791	-101 Reduced 8.9%	1,034 $230,000
Q3 2020 Oct 23, 2020	SELL	$177.16 - $215.33 $27,282 - $33,160	-154 Reduced 11.95%	1,135 $244,000
Q2 2020 Jul 15, 2020	BUY	$128.7 - $176.83 $165,894 - $227,933	1,289 New	1,289 $228,000
Q1 2020 Apr 16, 2020	SELL	$121.39 - $169.05 $175,651 - $244,615	-1,447 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$135.4 - $146.47 $9,071 - $9,813	-67 Reduced 4.43%	1,447 $209,000
Q2 2019 Jul 17, 2019	SELL	$124.88 - $143.73 $24,601 - $28,314	-197 Reduced 11.51%	1,514 $216,000
Q1 2019 Apr 17, 2019	BUY	$97.62 - $132.29 $167,027 - $226,348	1,711 New	1,711 $226,000

Others Institutions Holding DHR

# of Institutions

2,432

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.11M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Sippican Capital Advisors with notifications on news.

Account

Sippican Capital Advisors Danaher Corp Transaction History